NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B
StreetAccount Summary - Trading higher/lower: EU mid-morning
Anheuser-Busch InBev holder E.P.S. to sell 10M shares in company -- Reuters (€75.20, 0.00)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (92 total)
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (95 total)
Quick Take: Anheuser-Busch InBev slips ~2% despite solid H1 results (€72.70, -1.20)
StreetAccount Metrics Recap - Anheuser-Busch InBev Q2 Earnings (€73.90, 0.00)
Powered by FactSet Research Systems Inc.